Format
Sort by
Items per page

Send to

Choose Destination

Best matches for boyman_o:

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy. Zingg D et al. Cell Rep. (2017)

Interleukin-2: Biology, Design and Application. Arenas-Ramirez N et al. Trends Immunol. (2015)

Modulation of T cell responses by IL-2 and IL-2 complexes. Boyman O et al. Clin Exp Rheumatol. (2015)

Search results

Items: 1 to 20 of 60

1.

Editorial overview: Allergy and hypersensitivity: Emerging concepts in allergy and type 2 immunity.

Boyman O, Eggel A, Noti M.

Curr Opin Immunol. 2018 Oct;54:iii-v. doi: 10.1016/j.coi.2018.10.002. No abstract available.

PMID:
30342706
2.

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, Pinilla C, Santos R, Hammer C, Ortiz Y, Opitz L, Grönlund H, Rogler G, Boyman O, Reynolds R, Lutterotti A, Khademi M, Olsson T, Piehl F, Sospedra M, Martin R.

Cell. 2018 Sep 20;175(1):85-100.e23. doi: 10.1016/j.cell.2018.08.011. Epub 2018 Aug 30.

3.

Epigenetic mechanisms of tumor resistance to immunotherapy.

Arenas-Ramirez N, Sahin D, Boyman O.

Cell Mol Life Sci. 2018 Nov;75(22):4163-4176. doi: 10.1007/s00018-018-2908-7. Epub 2018 Aug 23. Review.

PMID:
30140960
4.

Regulation of neutrophils in type 2 immune responses.

Heeb LEM, Egholm C, Impellizzieri D, Ridder F, Boyman O.

Curr Opin Immunol. 2018 Oct;54:115-122. doi: 10.1016/j.coi.2018.06.009. Epub 2018 Jul 14. Review.

PMID:
30015087
5.

The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity.

Castro W, Chelbi ST, Niogret C, Ramon-Barros C, Welten SPM, Osterheld K, Wang H, Rota G, Morgado L, Vivier E, Raeber ME, Boyman O, Delorenzi M, Barras D, Ho PC, Oxenius A, Guarda G.

Nat Immunol. 2018 Aug;19(8):809-820. doi: 10.1038/s41590-018-0144-9. Epub 2018 Jul 2.

PMID:
29967452
6.

The role of cytokines in T-cell memory in health and disease.

Raeber ME, Zurbuchen Y, Impellizzieri D, Boyman O.

Immunol Rev. 2018 May;283(1):176-193. doi: 10.1111/imr.12644. Review.

PMID:
29664568
7.

The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation.

Wang Y, de Vallière C, Imenez Silva PH, Leonardi I, Gruber S, Gerstgrasser A, Melhem H, Weber A, Leucht K, Wolfram L, Hausmann M, Krieg C, Thomasson K, Boyman O, Frey-Wagner I, Rogler G, Wagner CA.

J Crohns Colitis. 2018 Feb 28;12(3):355-368. doi: 10.1093/ecco-jcc/jjx147.

8.

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.

Zingg D, Arenas-Ramirez N, Sahin D, Rosalia RA, Antunes AT, Haeusel J, Sommer L, Boyman O.

Cell Rep. 2017 Jul 25;20(4):854-867. doi: 10.1016/j.celrep.2017.07.007.

9.

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.

Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, Boyman O.

Sci Transl Med. 2016 Nov 30;8(367):367ra166.

PMID:
27903862
10.

Endogenous polyclonal anti-IL-1 antibody responses potentiate IL-1 activity during pathogenic inflammation.

Spohn G, Arenas-Ramirez N, Bouchaud G, Boyman O.

J Allergy Clin Immunol. 2017 Jun;139(6):1957-1965.e3. doi: 10.1016/j.jaci.2016.09.033. Epub 2016 Nov 7.

PMID:
27833025
11.

Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation.

Woytschak J, Keller N, Krieg C, Impellizzieri D, Thompson RW, Wynn TA, Zinkernagel AS, Boyman O.

Immunity. 2016 Jul 19;45(1):172-84. doi: 10.1016/j.immuni.2016.06.025.

12.

Inflammation-Induced CCR7 Oligomers Form Scaffolds to Integrate Distinct Signaling Pathways for Efficient Cell Migration.

Hauser MA, Schaeuble K, Kindinger I, Impellizzieri D, Krueger WA, Hauck CR, Boyman O, Legler DF.

Immunity. 2016 Jan 19;44(1):59-72. doi: 10.1016/j.immuni.2015.12.010.

13.

IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.

Fellmann F, Angelini F, Wassenberg J, Perreau M, Arenas Ramirez N, Simon G, Boyman O, Demaria O, Christen-Zaech S, Hohl D, Belfiore M, von Scheven-Gete A, Gilliet M, Bochud PY, Perrin Y, Beck Popovic M, Bart PA, Beckmann JS, Martinet D, Hofer M.

J Allergy Clin Immunol. 2016 Apr;137(4):1189-1196.e2. doi: 10.1016/j.jaci.2015.07.053. Epub 2015 Nov 20.

PMID:
26607704
14.

Interleukin-2: Biology, Design and Application.

Arenas-Ramirez N, Woytschak J, Boyman O.

Trends Immunol. 2015 Dec;36(12):763-777. doi: 10.1016/j.it.2015.10.003. Epub 2015 Nov 10. Review.

15.

Modulation of T cell responses by IL-2 and IL-2 complexes.

Boyman O, Kolios AG, Raeber ME.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S54-7. Epub 2015 Oct 12. Review.

16.

The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014.

Marschall K, Hoernes M, Bitzenhofer-Grüber M, Jandus P, Duppenthaler A, Wuillemin WA, Rischewski J, Boyman O, Heininger U, Hauser T, Steiner U, Posfay-Barbe K, Seebach J, Recher M, Hess C, Helbling A, Reichenbach J; Swiss PID Registry Working Group.

Clin Exp Immunol. 2015 Oct;182(1):45-50. doi: 10.1111/cei.12661. Epub 2015 Jul 29.

17.

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, Eiwegger T, Firinu D, Harr T, Knol E, Matucci A, Palomares O, Schmidt-Weber C, Simon HU, Steiner UC, Vultaggio A, Akdis CA, Spertini F.

Allergy. 2015 Jul;70(7):727-54. doi: 10.1111/all.12616. Epub 2015 Apr 24. Review.

PMID:
25819018
18.

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

Zingg D, Debbache J, Schaefer SM, Tuncer E, Frommel SC, Cheng P, Arenas-Ramirez N, Haeusel J, Zhang Y, Bonalli M, McCabe MT, Creasy CL, Levesque MP, Boyman O, Santoro R, Shakhova O, Dummer R, Sommer L.

Nat Commun. 2015 Jan 22;6:6051. doi: 10.1038/ncomms7051.

PMID:
25609585
19.

The European Society for Immunodeficiencies (ESID) registry 2014.

Grimbacher B; ESID Registry Working Party.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:18-20. doi: 10.1111/cei.12496. No abstract available.

20.

Use of enhanced interleukin-2 formulations for improved immunotherapy against cancer.

Rosalia RA, Arenas-Ramirez N, Bouchaud G, Raeber ME, Boyman O.

Curr Opin Chem Biol. 2014 Dec;23:39-46. doi: 10.1016/j.cbpa.2014.09.006. Epub 2014 Sep 29. Review.

Supplemental Content

Loading ...
Support Center